Bob Gatty
Bob Gatty, a former congressional aide, covers news from Washington for Urology Times.
Urology-specific quality measures are coming
Two electronic Clinical Quality Measures will help urologists report on prostate and bladder cancer care.
Congress says 'no' to Trump NIH budget cuts
The fiscal 2017 appropriations wrap-up package approved by Congress in early May included a $2 billion increase for the National Institutes of Health, despite a Trump administration request for a $1.2 billion reduction for the nation’s primary medical research facility. That bipartisan action, which funds the federal government through September, came in the face of President Trump’s demand to slash spending for domestic programs to pay for a huge increase in appropriations for defense.
Guarded approval for new USPSTF PSA grade
The new draft recommendation on PSA screening from the U.S. Preventive Services Task Force (USPSTF), which improves the previous D rating for all men to a C rating for those ages 55 to 69 years, has been met with guarded approval by three of the key national organizations representing urologists.
USPSTF reform: PSA at forefront of Capitol Hill hearing
Organized urology makes its case for USPSTF reform during a recent hearing of the House Energy and Commerce Health Subcommittee.
Urologists say independent payment advisory board defeat may still be possible
The re-election of President Obama and the strengthened numbers of Democrats in both the House and Senate mean that key provisions of the Affordable Care Act are likely to be implemented over the next 2 years.
Federal government to crack down on Medicare upcoding
A recent report from the Center for Public Integrity found that during a 10-year period, physicians increasingly billed Medicare for higher paying codes than in the past.
Department of Health and Human Services makes concessions on electronic health record incentives
The recently published meaningful use Stage 2 final rule will directly affect urology practices.
Election Day holds many keys to urologists' future
The decisions by the men and women who are elected will determine whether physicians who treat Medicare are fairly reimbursed; whether the Independent Payment Advisory Board (IPAB) is allowed to continue; and even how government agencies, task forces, and advisory boards that make recommendations on specific testing and treatment protocols are allowed to function.
Organized urology reiterates Independent Payment Advisory Board concerns
For urologists who strongly oppose key provisions of the Patient Protection & Affordable Care Act (ACA), upheld by the U.S. Supreme Court in late June, the best hope for change may lie in the ballot box rather than in the halls of Congress.
Feds crack down on urology billing fraud, abuse
With all of the pressure on the federal government to curtail spending, the U.S. Department of Health and Human Services (HHS) is not kidding around when it comes to investigating and prosecuting Medicare fraud and abuse.